021 Unprotected left main coronary artery angioplasty in octogenarians: characteristics, results and predictors of long term outcomes

Rekik, S.; Brunet, Jerome; Hager, Francois Xavier; Bayet, Gilles; Meille, Laurent; Quatre, Jean Michel; Sainsous, Joël

doi:10.1016/s1878-6480(11)70023-4

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cardiovascular disease and more particularly ischaemic heart disease among nonagenarians is the most studied disease in the literature. In the article of Biondi Zoccai G et al [13], a review of 18 articles (1082 patients) on the subject of effectiveness and tolerance of percutaneous coronary intervention (PCI) was detailed [32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49]. Among these studies, there was a great variability in patient selection, as well as features and results.…”

Section: Medical Treatment Of Nonagenarian Patientsmentioning

confidence: 99%

“…Implantation of drug-eluting stents remained very different between articles (from 5% [39] to 100% [32] of patients). Most of the patients had a multivessel coronary artery disease [34,36,40,46,48]. Clinical results were accordingly highly variable, despite a median short-term (in-hospital to one month follow-up) mortality of 14% and a long term (six month to longer follow-up) mortality of 18%.…”

Section: Medical Treatment Of Nonagenarian Patientsmentioning

confidence: 99%

See 1 more Smart Citation

General management of nonagenarian patients: a review of the literature

Rivoirard¹,

Chargari²,

Trone³

et al. 2014

Swiss Med Wkly

View full text Add to dashboard Cite

The number of nonagenarian people in the world is steadily growing. This phenomenon will increase in future years: in 2050, world population prospects estimate 71.16 million people aged 90 years or older. The two main causes of death among people aged 85 years or more in Europe in 2003 were cardiovascular and cerebrovascular diseases and cancers. However, the elderly are often excluded from clinical trials; they are underrepresented in clinical registries and especially nonagenarians. Care (medical, surgical, oncology) of these very elderly is currently insufficiently based on scientific recommendations. For the physician, the choice to treat or not to treat very elderly patients (for fear of side effects) is difficult. Oncology is particularly affected by this problem. Here we review these different fields of internal medicine management of nonagenarian patients with a special focus on oncology and on comprehensive geriatric assessment as a base for all care decision taking.

show abstract